These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22736917)

  • 1. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.
    Yang J; Zhang JX; Wang H; Wang GL; Hu QG; Zheng QC
    World J Gastroenterol; 2012 Jun; 18(23):2938-47. PubMed ID: 22736917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency and FOXP3 expression of human CD8
    Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
    Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.
    Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L
    Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
    Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
    Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
    Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.
    Du Y; Chen X; Huang ZM; Ye XH; Niu Q
    Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
    Cao C; Chai Y; Shou S; Wang J; Huang Y; Ma T
    Int Immunopharmacol; 2018 Jan; 54():169-176. PubMed ID: 29149705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TLR4 and its effect on Treg cells in early pregnancy decidual stromal cells after lipopolysaccharide treating.
    Wu A; Liu F; Liu X; Feng X; Lin H
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():209-214. PubMed ID: 30798978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
    Wiedemann GM; Röhrle N; Makeschin MC; Fesseler J; Endres S; Mayr D; Anz D
    Pathology; 2019 Oct; 51(6):586-592. PubMed ID: 31445808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X; Li B; Ye H; Long D
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells, especially ICOS
    Tu JF; Ding YH; Ying XH; Wu FZ; Zhou XM; Zhang DK; Zou H; Ji JS
    Sci Rep; 2016 Oct; 6():35056. PubMed ID: 27725696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD4+CD25+CD127
    Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
    Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.